Yu‐Luan Chen

789 total citations
34 papers, 625 citations indexed

About

Yu‐Luan Chen is a scholar working on Spectroscopy, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Yu‐Luan Chen has authored 34 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Spectroscopy, 9 papers in Molecular Biology and 8 papers in Analytical Chemistry. Recurrent topics in Yu‐Luan Chen's work include Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Analytical Methods in Pharmaceuticals (7 papers). Yu‐Luan Chen is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Mass Spectrometry Techniques and Applications (7 papers) and Analytical Methods in Pharmaceuticals (7 papers). Yu‐Luan Chen collaborates with scholars based in United States, Canada and Japan. Yu‐Luan Chen's co-authors include Xiangyu Jiang, Naidong Weng, Wilson Z. Shou, Lars Konermann, Shahzad Akhtar, D. J. Douglas, Anne M. Larson, Mary F. Hébert, Jeong Mi Park and Vincent Lee and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Analytical Chemistry.

In The Last Decade

Yu‐Luan Chen

33 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu‐Luan Chen United States 14 302 212 131 72 65 34 625
Timo Mauriala Finland 19 294 1.0× 352 1.7× 98 0.7× 66 0.9× 89 1.4× 22 896
Gwyn A. Lord United Kingdom 14 178 0.6× 238 1.1× 57 0.4× 58 0.8× 120 1.8× 33 708
Candice B. Kissinger United States 13 437 1.4× 297 1.4× 89 0.7× 32 0.4× 101 1.6× 17 730
Rolf Aderjan Germany 18 183 0.6× 190 0.9× 92 0.7× 98 1.4× 75 1.2× 36 876
Wiktoria Struck‐Lewicka Poland 16 260 0.9× 612 2.9× 98 0.7× 43 0.6× 118 1.8× 42 1.1k
Daniel J. Liberato United States 20 338 1.1× 342 1.6× 75 0.6× 106 1.5× 47 0.7× 38 970
Nobuyasu Mizuno Japan 16 145 0.5× 151 0.7× 98 0.7× 47 0.7× 39 0.6× 48 630
Akihiro Miki Japan 28 590 2.0× 413 1.9× 188 1.4× 76 1.1× 128 2.0× 104 1.9k
Valquíria Aparecida Polisel Jabor Brazil 17 187 0.6× 164 0.8× 90 0.7× 85 1.2× 132 2.0× 34 630
Jimmy Flarakos United States 14 158 0.5× 307 1.4× 56 0.4× 36 0.5× 52 0.8× 39 667

Countries citing papers authored by Yu‐Luan Chen

Since Specialization
Citations

This map shows the geographic impact of Yu‐Luan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Luan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Luan Chen more than expected).

Fields of papers citing papers by Yu‐Luan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Luan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Luan Chen. The network helps show where Yu‐Luan Chen may publish in the future.

Co-authorship network of co-authors of Yu‐Luan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Luan Chen. A scholar is included among the top collaborators of Yu‐Luan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Luan Chen. Yu‐Luan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lew, Robert, Gerald R. Galluppi, Yu‐Luan Chen, et al.. (2025). An open‐label study on ulotaront's effects on insulin‐glucose regulation in schizophrenia patients with metabolic syndrome and prediabetes: Part I. Diabetes Obesity and Metabolism. 28(1). 103–111.
2.
Chen, Yu‐Luan, et al.. (2024). Phase field modeling for fatigue fracture in functional graded materials. Acta Mechanica. 235(8). 5239–5255. 4 indexed citations
3.
Chen, Yu‐Luan, Guangqing Xiao, Snežana Milanović, et al.. (2023). A Phase I, Open-Label, Fixed Sequence Study to Investigate the Effect of Cytochrome P450 2D6 Inhibition on the Pharmacokinetics of Ulotaront in Healthy Subjects. Clinical Pharmacokinetics. 62(12). 1755–1763. 4 indexed citations
4.
Chen, Yu‐Luan, Snežana Milanović, Lei Shi, et al.. (2023). Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans. Neurology and Therapy. 12(3). 815–832. 4 indexed citations
5.
Xiao, Guangqing, et al.. (2022). In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia. Pharmaceutical Research. 39(5). 837–850. 11 indexed citations
6.
Fu, Siqing, David Piccioni, Hongtao Liu, et al.. (2021). A phase I study of the WT2725 dosing emulsion in patients with advanced malignancies. Scientific Reports. 11(1). 22355–22355. 13 indexed citations
7.
Chen, Yu‐Luan, et al.. (2021). A sensitive LC-MS/MS method for simultaneous quantification of ulotaront and its N-desmethyl metabolite in human plasma and application to a clinical study. Journal of Pharmaceutical and Biomedical Analysis. 207. 114404–114404. 7 indexed citations
9.
Shi, Lei, Armand G. Ngounou Wetie, Weimin Wang, & Yu‐Luan Chen. (2020). Validation of a sensitive and specific LC–MS/MS method and application to evaluate the systemic exposure and bioavailability of glycopyrrolate via different drug delivery approaches/devices. Biomedical Chromatography. 34(9). e4899–e4899. 1 indexed citations
10.
Chen, Yu‐Luan, et al.. (2020). A sensitive liquid chromatography-tandem mass spectrometry method for quantitative determination of dasotraline in human plasma and its clinical application. Journal of Pharmaceutical and Biomedical Analysis. 191. 113611–113611. 1 indexed citations
11.
Fu, Siqing, David Piccioni, Hongtao Liu, et al.. (2017). Initial phase 1 study of WT2725 dosing emulsion in patients with advanced malignancies.. Journal of Clinical Oncology. 35(15_suppl). 2066–2066. 7 indexed citations
12.
Sramek, John J., Larry W. Hardy, P. R. Bieck, et al.. (2016). Exploratory Biomarker Study of the Triple Reuptake Inhibitor SEP‐432 Compared to the Dual Reuptake Inhibitor Duloxetine in Healthy Normal Subjects. CNS Neuroscience & Therapeutics. 22(5). 404–412. 3 indexed citations
14.
Chen, Yu‐Luan, et al.. (2005). In vivo metabolism for the hydroxylation of FK778 to the metabolite M3 in humans studied by enantioselective liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 19(18). 2681–2688. 2 indexed citations
15.
Hébert, Mary F., Jeong Mi Park, Yu‐Luan Chen, Shahzad Akhtar, & Anne M. Larson. (2003). Effects of St. John's Wort (Hypericum perforatum) on Tacrolimus Pharmacokinetics in Healthy Volunteers. The Journal of Clinical Pharmacology. 44(1). 89–94. 72 indexed citations
17.
Shou, Wilson Z., et al.. (2002). Ultrafast liquid chromatography/tandem mass spectrometry bioanalysis of polar analytes using packed silica columns. Rapid Communications in Mass Spectrometry. 16(17). 1613–1621. 36 indexed citations
18.
Chen, Yu‐Luan, et al.. (2002). Simultaneous determination of hydrocodone and hydromorphone in human plasma by liquid chromatography with tandem mass spectrometric detection. Journal of Chromatography B. 769(1). 55–64. 25 indexed citations
19.
Weng, Naidong, Yu‐Luan Chen, Wilson Z. Shou, & Xiangyu Jiang. (2001). Importance of injection solution composition for LC–MS–MS methods. Journal of Pharmaceutical and Biomedical Analysis. 26(5-6). 753–767. 40 indexed citations
20.
Weng, Naidong, Wilson Z. Shou, Yu‐Luan Chen, & Xiangyu Jiang. (2001). Novel liquid chromatographic–tandem mass spectrometric methods using silica columns and aqueous–organic mobile phases for quantitative analysis of polar ionic analytes in biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 754(2). 387–399. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026